Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib

Overview of attention for article published in Circulation: Genomic and Precision Medicine, January 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#18 of 1,062)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 15 X posts from 14 X users, with an upper bound of 50,831 followers.

@VUMChealth DR: https://t.co/cvHKeSpoxk no difference in dalcetrapib response from placebo. Group in Canada then https://t.co/496i0phaRT looked at GWAS of response.

@altmetric 2015 Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib https://t.co/7AhrOIzof8

Est ce que la génomique va sauver les inhibiteurs de CETP? https://t.co/tVVQtWDR29

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.